Exploring Wellbeing Outcomes in Adolescents Using Bifidobacterium Longum, 1714™: a Prospective Open-Label Real-World Study
Starting soon · Not applicable
Conditions studied: Healthy Young Adults
In brief
The purpose of this study is to evaluate changes in self-reported wellbeing outcomes in adolescents. Bifidobacterium longum, 1714™ has previously been associated with beneficial effects on stress-related outcomes, sleep quality, subjective wellbeing and aspects of cognitive performance, however evidence in adolescents is limited. This study will evaluate changes in outcomes related to anxiety, sleep, fatigue, cognitive function and other wellbeing outcomes following daily consumption of Bifidobacterium longum, 1714™ under real-world conditions.
Key facts
- Study ID
- NCT07752342
- Run by
- Novonesis
- People needed
- 150
- Starts
- 2026-09-01
- Expected to finish
- 2027-04-01
- Last updated by the study team
- 2026-08-07
Who can join
Age: 15 and older, up to 17. Sex: any. Healthy volunteers: accepted.
Where it is running
- Comet Clinical — Cardiff, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.